AseptiScope
- Industry
- Medical Equipment and Supplies Manufacturing
- Founded Year
- 2016
- Headquarters
- 4061 Stephens Street, San Diego, CA 92103, United States
- Employee Count
- 21
Key People
-
Scott W. Mader - Co-founder, President, and CEO
Email: smader@aseptiscope.com
- William Frank Peacock - Co-founder and Chief Medical Officer
- Kelly M. Powers - Co-founder and Chief Operating Officer
- Alan S. Maisel - Co-founder and Chief Clinical Officer
- Kathleen Winer - Chief Financial Officer
- Steve Daly - Chief Commercial Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The founding team comprises experienced medical professionals and entrepreneurs with a track record in MedTech innovation.
AseptiScope's leadership includes individuals with significant experience in medical device development and commercialization, enhancing the company's credibility and potential for success.
- Clinical Need
-
Aspect: Very Strong
Summary: The DiskCover System addresses the critical issue of stethoscope contamination, a significant vector for healthcare-associated infections.
Stethoscope contamination is a well-documented issue in healthcare settings. AseptiScope's solution offers a practical and effective method to mitigate this risk, aligning with infection control priorities.
- Competition
-
Aspect: First mover
Summary: AseptiScope appears to be the first to market with a touch-free stethoscope barrier dispensing system.
While first-mover advantage can be beneficial, it also requires significant resources to educate the market and establish demand for a novel product.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology behind the DiskCover System is straightforward and well-understood.
The DiskCover System utilizes existing technologies in a novel application, minimizing technical uncertainties and facilitating smoother development and manufacturing processes.
- Patent
-
Aspect: Very Strong
Summary: AseptiScope holds patents for its DiskCover System, providing robust intellectual property protection.
The company's patents safeguard its innovations, potentially deterring competitors and providing leverage in the market.
- Financing
-
Aspect: Well-funded
Summary: AseptiScope has successfully raised significant funding, including exceeding its Series A target.
The company's ability to secure funding beyond its targets indicates strong investor confidence and provides the necessary resources for growth and commercialization.
- Regulatory
-
Aspect: 510k/PMA
Summary: The DiskCover System has obtained necessary regulatory approvals for market entry.
Achieving regulatory approval is a critical milestone, allowing the company to legally market and sell its product within the healthcare industry.
Opportunity Rollup
- Odds of Success
- 3.2
- Peak Market Share
- 3.75
- Segment CAGR
- 5.4%
- Market Segment
- Medical Equipment and Supplies Manufacturing
- Market Sub Segment
- Infection Control Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.56 |
| 3 | 1.31 |
| 4 | 2.62 |
| 5 | 3.75 |
Key Takeaway
AseptiScope's innovative approach to stethoscope hygiene addresses a critical need in infection control, positioning the company for significant growth in the healthcare market.